Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 15, 2026

Daily Signals

2478 companies scored · 2026-10-15 run in progress: 2311 of ~5380 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-15 Cut-offs from the 2026-10-14 run
Companies scored 2478 IC ≥ 0 · market cap ≥ $100M
Median forecast +3.09% Total · 90D
Long–short spread +5.08% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 90D
Rating changes ▲ 54 ▼ 48 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · All

2478 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1401 BLBLACKLINE, INC. Technology 0.11 $1.7B Neutral +1.03% +3.14% ·
1402 MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. Life Sciences 0.62 $1.7B Unlock rating and forecasts
1403 PSNLPersonalis, Inc. Industrial Applications and Services 0.00 $1.7B Unlock rating and forecasts
1404 SEPNSepterna, Inc. Life Sciences 0.08 $1.7B Unlock rating and forecasts
1405 STBAS&T BANCORP INC Finance 0.12 $1.7B Unlock rating and forecasts
1406 XHRXenia Hotels & Resorts, Inc. Real Estate & Construction 0.22 $1.7B Neutral +1.01% +2.65% ·
1407 HOPEHOPE BANCORP INC Finance 0.03 $1.7B Unlock rating and forecasts
1408 ARDTArdent Health, Inc. Industrial Applications and Services 0.34 $1.7B Neutral +0.86% +3.26% ·
1409 ALNTALLIENT INC Industrial Applications and Services 0.54 $1.7B Unlock rating and forecasts
1410 XRAYDENTSPLY SIRONA Inc. Industrial Applications and Services 0.09 $1.7B Unlock rating and forecasts
1411 DCOMDime Commercial Bancshares, Inc. /NY/ Finance 0.22 $1.7B Unlock rating and forecasts
1412 NEXANexa Resources S.A. Energy & Transportation 0.19 $1.7B Unlock rating and forecasts
1413 PLABPHOTRONICS INC Manufacturing 0.63 $1.7B Unlock rating and forecasts
1414 FLOCFlowco Holdings Inc. Technology 0.14 $1.7B Unlock rating and forecasts
1415 GICGLOBAL INDUSTRIAL Co Trade & Services 0.23 $1.7B Neutral +0.67% +2.93% ·
1416 EVCMEverCommerce Inc. Technology 0.00 $1.7B Unlock rating and forecasts
1417 BYBYLINE BANCORP, INC. Finance 0.23 $1.7B Neutral +0.97% +3.30% ·
1418 NUVBNuvation Bio Inc. Life Sciences 0.35 $1.6B Unlock rating and forecasts
1419 HAPNHappen, Inc. Finance 0.19 $1.6B Unlock rating and forecasts
1420 ATEXAnterix Inc. Technology 0.73 $1.6B Neutral +1.01% +3.15% ·
1421 WLTHWEALTHFRONT CORP Finance or Crypto Assets 0.00 $1.6B Unlock rating and forecasts
1422 TGLSTecnoglass Holdings Inc. Manufacturing 0.67 $1.6B Neutral +1.24% +2.88% ·
1423 NEXTNextDecade Corp Energy & Transportation 0.27 $1.6B Unlock rating and forecasts
1424 AZTAAzenta, Inc. Technology 0.59 $1.6B Unlock rating and forecasts
1425 CNXCConcentrix Corp Trade & Services 0.12 $1.6B Unlock rating and forecasts
1426 ZBIOZenas BioPharma, Inc. Life Sciences 0.17 $1.6B Unlock rating and forecasts
1427 BFCBank First Corp Finance 0.23 $1.6B Unlock rating and forecasts
1428 AVEXAEVEX Corp. Manufacturing 0.63 $1.6B Unlock rating and forecasts
1429 GLOBGlobant S.A. Technology 0.25 $1.6B Neutral +1.05% +2.46% ·
1430 OMCLOMNICELL, INC. Technology 0.52 $1.6B Neutral +0.75% +2.77% ·
1431 KOSKosmos Energy Ltd. Energy & Transportation 0.51 $1.6B Neutral +0.57% +2.21% ·
1432 ATECAlphatec Holdings, Inc. Industrial Applications and Services 0.59 $1.6B Unlock rating and forecasts
1433 NOMDNomad Foods Ltd Manufacturing 0.42 $1.6B Neutral +0.81% +2.17% ·
1434 NVCRNovoCure Ltd Industrial Applications and Services 0.51 $1.6B Unlock rating and forecasts
1435 ANIPANI PHARMACEUTICALS INC Life Sciences 0.38 $1.6B Unlock rating and forecasts
1436 GENBGenerate Biomedicines, Inc. Life Sciences 0.10 $1.6B Unlock rating and forecasts
1437 HUBGHub Group, Inc. Energy & Transportation 0.30 $1.6B Unlock rating and forecasts
1438 NTLAIntellia Therapeutics, Inc. Life Sciences 0.49 $1.6B Unlock rating and forecasts
1439 WBWEIBO Corp Technology 0.13 $1.6B Unlock rating and forecasts
1440 LOBLive Oak Bancshares, Inc. Finance 0.25 $1.6B Unlock rating and forecasts
1441 QCRHQCR HOLDINGS INC Finance 0.10 $1.6B Neutral +0.68% +3.01% ·
1442 LILALiberty Latin America Ltd. Technology 0.43 $1.6B Unlock rating and forecasts
1443 GSHDGoosehead Insurance, Inc. Finance 0.53 $1.6B Neutral +1.30% +3.35% ·
1444 EFOREverforth Inc Trade & Services 0.77 $1.6B Neutral +1.12% +3.14% ·
1445 OCULOCULAR THERAPEUTIX, INC Life Sciences 0.16 $1.6B Neutral +1.73% +2.51% ·
1446 CTSCTS CORP Manufacturing 0.49 $1.6B Neutral +1.05% +2.61% ·
1447 OBKOrigin Bancorp, Inc. Finance 0.54 $1.6B Neutral +0.98% +2.88% ·
1448 KEELKeel Infrastructure Corp. Finance or Crypto Assets 0.14 $1.6B Unlock rating and forecasts
1449 CMPSCOMPASS Pathways plc Life Sciences 0.13 $1.6B Unlock rating and forecasts
1450 DEIDouglas Emmett Inc Real Estate & Construction 0.36 $1.6B Unlock rating and forecasts
1401–1450 of 2478 Previous Next
Since the previous run

Rating changes

▲ 54▼ 48
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-14) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.